This document arises from the NANOGENOTOX Joint Action which has received funding from the European Union, in the framework of the Health Programme under Grant Agreement n°2009 21. This publication reflects only the author’s views and the Community is not liable for any use that may be made of the information contained therein
document was produced with the financial contribution of the European Commission. Opinions expressed...
Poster -review conference, 09 November 2017-EMPIR Grant Agreement 17NRM03 EUCoM - This project has...
This project received financial support from- among others- the European Com-mission in the framewor...
Document summarizing the beneficiaries strategy related to the dissemination and exploitation of the...
Programme (FP7/2007-2013) under grant agreement n°242482. This document only reflects the views of t...
This project has received funding from the European Union’s Seventh Framework Programme for research...
Initial version of DMPREsolution has received funding from the Innovative Medicines Initiative 2 Joi...
General trifold of GLOMICAVE projectThis project has received funding from the European Union's Hori...
This document is issued for the party which commissioned it and for specific purposes connected with...
for research, technological development and demonstration under grant agreement no 26680
Commission of the European Union Rockefeller Foundation The information contained in the publication...
SYNTHEMA First Joint Press ReleaseThis project has received funding from the European Union's Call f...
This project has received funding from the European Union's Horizon 2020 research and innovation pro...
The project received funding from the European Union’s Horizon 2020 research and innovation programm...
EU-HIP Deliverable D3.1 Evaluation plan. This activity is supported by co-funding from the European...
document was produced with the financial contribution of the European Commission. Opinions expressed...
Poster -review conference, 09 November 2017-EMPIR Grant Agreement 17NRM03 EUCoM - This project has...
This project received financial support from- among others- the European Com-mission in the framewor...
Document summarizing the beneficiaries strategy related to the dissemination and exploitation of the...
Programme (FP7/2007-2013) under grant agreement n°242482. This document only reflects the views of t...
This project has received funding from the European Union’s Seventh Framework Programme for research...
Initial version of DMPREsolution has received funding from the Innovative Medicines Initiative 2 Joi...
General trifold of GLOMICAVE projectThis project has received funding from the European Union's Hori...
This document is issued for the party which commissioned it and for specific purposes connected with...
for research, technological development and demonstration under grant agreement no 26680
Commission of the European Union Rockefeller Foundation The information contained in the publication...
SYNTHEMA First Joint Press ReleaseThis project has received funding from the European Union's Call f...
This project has received funding from the European Union's Horizon 2020 research and innovation pro...
The project received funding from the European Union’s Horizon 2020 research and innovation programm...
EU-HIP Deliverable D3.1 Evaluation plan. This activity is supported by co-funding from the European...
document was produced with the financial contribution of the European Commission. Opinions expressed...
Poster -review conference, 09 November 2017-EMPIR Grant Agreement 17NRM03 EUCoM - This project has...
This project received financial support from- among others- the European Com-mission in the framewor...